Answers are grounded in this paper and cite their sources.
Morphine is a natural phenanthrene-derived alkaloid that alleviates moderate to severe pain by activating μ-opioid receptors, which inhibit adenylate cyclase and reduce cAMP levels. Measuring its concentrations is crucial for optimizing pain management, preventing overdose, and minimizing side effects, abuse, and addiction in clinical practice. In this work, an optical Rayleigh light scattering (RLS) probe based on silver plasmonic nanoparticles was developed for the detection of morphine in exhaled breath condensate (EBC). Silver nanocrystals (Ag NCs) were synthesized in the presence of bovine serum albumin (BSA) as a stabilizing agent, and the experimental conditions were optimized to achieve maximal RLS response. The probe exhibited a strong linear correlation between analytical response and morphine concentration across 0.02–1.6 µg/mL, with a detection limit of 0.007 µg/mL. Morphine determination in patients’ EBC samples confirmed the analytical applicability and reproducibility of the herein-validated method. To the best of our knowledge, this is the first RLS-based system for morphine detection. Morphine is a powerful medication used to treat severe pain, but monitoring its levels in patients is essential to prevent overdose and side effects. Currently, measuring morphine requires blood samples and complex laboratory equipment, which can be uncomfortable for patients and time-consuming for healthcare providers. This research introduces a new, simpler method to detect morphine. The technique uses tiny silver particles, called nanoclusters, that are coated with a protein and act as a sensor. When morphine is present, these nanoparticles cluster together, causing a change in light scattering that can be measured with a standard laboratory instrument. The new method is highly sensitive, able to detect very small amounts of morphine in breath samples with acceptable accuracy. Testing on patient samples confirmed the method works reliably, with recovery rates above 96%, meaning it accurately measures the drug present. This approach offers several advantages over traditional methods: it is noninvasive, rapid, and requires minimal sample preparation. The EBC analysis could make pain management safer by allowing healthcare providers to monitor morphine levels more conveniently and frequently. While more research with larger patient groups is needed before it can be used in hospitals, this technology represents a promising step toward better, patient-friendly therapeutic drug monitoring.
No takes yet. Share an insight, caveat, or question.
Latifpour et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: